← Leaderboards
Thomas Hope
Northwestern University
$67,101,837
Attributed
$83,172,998
Total exposure
38
Grants
35
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$89,330,116 · 39
By mechanism
R01$30,527,327 · 9
UM1$17,890,653 · 1
P01$15,460,255 · 10
R37$9,125,454 · 1
P50$7,132,408 · 4
R33$3,037,388 · 2
Top collaborators
- Paul D Bieniasz5 shared
- Patrick Franklin Kiser5 shared
- Ramon Lorenzo-Redondo4 shared
- Elena Martinelli4 shared
- Adam Burgener3 shared
- Nichole Rose Klatt3 shared
Most similar at Northwestern University
Same institution · by research overlap
- Elena Martinelli$12,661,037
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsVirusViralTissuesInfectionInsightDesignTransmission ProcessImageLaboratoriesMucous MembranePreventBaseAreaProteinsHiv InfectionsParticleMacaca MulattaSignal TransductionBiologicalSiteComplexSexual TransmissionVirion
Grant awards (136)
Unraveling the Mechanisms of HIV Persistence and Rebound$1,548,796
P01 · FY2025 · AI · contact PI
Role of myeloid cells in CNS and systemic reservoirs and rebound$896,082
R01 · FY2025 · MH · contact PI
Identification of the Initial Targets of Transmission$891,413
R37 · FY2025 · AI · contact PI
Nonhuman Primate Core$517,938
P01 · FY2025 · AI · contact PI
Project 2: Revealing Viral Population and Host Environment Dynamics of SIV Tissue Reservoir$404,842
P01 · FY2025 · AI · contact PI
Project 1: Dissecting Persistent Virus Reservoirs in Tissues$338,146
P01 · FY2025 · AI · contact PI
Exploration into the Forgotten HIV Reservoir with Models of HIV/SIV Persistence in Mucosal Tissues$225,000
P01 · FY2025 · AI · contact PI
Administrative Core$62,870
P01 · FY2025 · AI · contact PI
Unraveling the Mechanisms of HIV Persistence and Rebound$1,548,481
P01 · FY2024 · AI · contact PI
Functionally Defining HIV-Host Interactions During the Early HIV-1 Lifecycle$1,348,086
R01 · FY2024 · AI · contact PI
Role of myeloid cells in CNS and systemic reservoirs and rebound$1,026,035
R01 · FY2024 · MH · contact PI
Identification of the Initial Targets of Transmission$891,371
R37 · FY2024 · AI · contact PI
Characterizing Mucosal Changes in the FRT Leading to Increased HIV Acquisition$660,819
R01 · FY2024 · AI · contact PI
Project 1: Dissecting Persistent Virus Reservoirs in Tissues$438,072
P01 · FY2024 · AI · contact PI
Viral Pathogenesis Core$154,957
P30 · FY2024 · AI · contact PI
Administrative Core$62,688
P01 · FY2024 · AI · contact PI
Unraveling the Mechanisms of HIV Persistence and Rebound$1,548,855
P01 · FY2023 · AI · contact PI
Functionally Defining HIV-Host Interactions During the Early HIV-1 Lifecycle$1,351,668
R01 · FY2023 · AI · contact PI
Role of myeloid cells in CNS and systemic reservoirs and rebound$1,055,701
R01 · FY2023 · MH · contact PI
Identification of the Initial Targets of Transmission$894,537
R37 · FY2023 · AI · contact PI
Characterizing Mucosal Changes in the FRT Leading to Increased HIV Acquisition$665,443
R01 · FY2023 · AI · contact PI
Project 1: Dissecting Persistent Virus Reservoirs in Tissues$237,726
P01 · FY2023 · AI · contact PI
Viral Pathogenesis Core$80,464
P30 · FY2023 · AI · contact PI
Administrative Core$60,192
P01 · FY2023 · AI · contact PI
Unraveling the Mechanisms of HIV Persistence and Rebound$1,510,986
P01 · FY2022 · AI · contact PI
Functionally Defining HIV-Host Interactions During the Early HIV-1 Lifecycle$1,355,103
R01 · FY2022 · AI · contact PI
Role of myeloid cells in CNS and systemic reservoirs and rebound$1,064,451
R01 · FY2022 · MH · contact PI
Identification of the Initial Targets of Transmission$910,732
R37 · FY2022 · AI · contact PI
Barrier integrity, microbiome and HIV target cell interactions in the human male genital tract pre and post circumcision$623,966
R01 · FY2022 · DK · contact PI
Project 1: Dissecting Persistent Virus Reservoirs in Tissues$230,163
P01 · FY2022 · AI · contact PI
Viral Pathogenesis Core$227,493
P30 · FY2022 · AI · contact PI
Administrative Core$45,458
P01 · FY2022 · AI · contact PI
Functionally Defining HIV-Host Interactions During the Early HIV-1 Lifecycle$1,332,934
R01 · FY2021 · AI · contact PI
HIV Core Trafficking and Restriction$848,106
P50 · FY2021 · AI · contact PI
Identification of the Initial Targets of Transmission$778,558
R37 · FY2021 · AI · contact PI
Identification of the Initial Targets of Transmission$758,437
R37 · FY2021 · AI · contact PI
Characterizing Mucosal Changes in the FRT Leading to Increased HIV Acquisition$684,749
R01 · FY2021 · AI · contact PI
Dissecting Early Virus Reservoirs in Tissues$386,327
P01 · FY2021 · AI · contact PI
Viral Pathogenesis Core$143,058
P30 · FY2021 · AI · contact PI
Functionally Defining HIV-Host Interactions During the Early HIV-1 Lifecycle$1,451,886
R01 · FY2020 · AI · contact PI
Identification of the Initial Targets of Transmission$786,043
R37 · FY2020 · AI · contact PI
Identification of the Initial Targets of Transmission$786,043
R37 · FY2020 · AI · contact PI
HIV Core Trafficking and Restriction$712,302
P50 · FY2020 · AI · contact PI
Characterizing Mucosal Changes in the FRT Leading to Increased HIV Acquisition$675,996
R01 · FY2020 · AI · contact PI
Barrier integrity, microbiome and HIV target cell interactions in the human male genital tract pre and post circumcision$592,255
R01 · FY2020 · DK · contact PI
Harnessing MUC16-IgG Interactions to Enhance HIV Vaccine Function$563,535
R01 · FY2020 · AI · contact PI
Mucosal mechanisms of altered HIV susceptability in adolescents$513,062
R01 · FY2020 · AI
Antibody function at the portal of entry$464,823
P01 · FY2020 · AI · contact PI
Dissecting Early Virus Reservoirs in Tissues$421,973
P01 · FY2020 · AI · contact PI
Viral Pathogenesis Core$272,894
P30 · FY2020 · AI · contact PI
Sustained Long Acting Prevention Against HIV Program Operation$3,346,920
UM1 · FY2019 · AI · contact PI
Identification of the Initial Targets of Transmission$793,398
R37 · FY2019 · AI · contact PI
HIV Core Trafficking and Restriction$780,210
P50 · FY2019 · AI · contact PI
Characterizing Mucosal Changes in the FRT Leading to Increased HIV Acquisition$707,472
R01 · FY2019 · AI · contact PI
Barrier integrity, microbiome and HIV target cell interactions in the human male genital tract pre and post circumcision$593,830
R01 · FY2019 · DK · contact PI
Harnessing MUC16-IgG Interactions to Enhance HIV Vaccine Function$570,632
R01 · FY2019 · AI · contact PI
Antibody function at the portal of entry$467,463
P01 · FY2019 · AI · contact PI
Dissecting Early Virus Reservoirs in Tissues$445,766
P01 · FY2019 · AI · contact PI
Core E: Viral Pathogenesis Core$66,022
P30 · FY2019 · AI · contact PI
2019 CFAR Women and HIV Symposium$25,000
R13 · FY2019 · AI · contact PI
Sustained Long Acting Prevention Against HIV Program Operation$3,501,400
UM1 · FY2018 · AI · contact PI
Identification of the Initial Targets of Transmission$801,430
R37 · FY2018 · AI · contact PI
HIV Core Trafficking and Restriction$743,381
P50 · FY2018 · GM · contact PI
Barrier integrity, microbiome and HIV target cell interactions in the human male genital tract pre and post circumcision$608,278
R01 · FY2018 · DK · contact PI
Harnessing MUC16-IgG Interactions to Enhance HIV Vaccine Function$577,572
R01 · FY2018 · AI · contact PI
Dissecting Early Virus Reservoirs in Tissues$540,239
P01 · FY2018 · AI · contact PI
Core E: Viral Pathogenesis Core$447,932
P30 · FY2018 · AI · contact PI
Antibody function at the portal of entry$364,658
P01 · FY2018 · AI · contact PI
Mucosal mechanisms of altered HIV susceptibility in adolescents$281,171
R01 · FY2018 · AI
Sustained Long Acting Prevention Against HIV Program Operation$3,525,315
UM1 · FY2017 · AI · contact PI
Identification of the Initial Targets of Transmission$833,492
R37 · FY2017 · AI · contact PI
HIV Core Trafficking and Restriction$780,589
P50 · FY2017 · GM · contact PI
Mucosal mechanisms of altered HIV susceptibility in adolescents$722,492
R01 · FY2017 · AI
Barrier integrity, microbiome and HIV target cell interactions in the human male genital tract pre and post circumcision$638,625
R01 · FY2017 · DK · contact PI
Harnessing MUC16-IgG Interactions to Enhance HIV Vaccine Function$583,563
R01 · FY2017 · AI · contact PI
Core E: Viral Pathogenesis Core$558,937
P30 · FY2017 · AI · contact PI
Dissecting Early Virus Reservoirs in Tissues$458,557
P01 · FY2017 · AI · contact PI
Antibody function at the portal of entry$429,351
P01 · FY2017 · AI · contact PI
Sustained Long Acting Prevention Against HIV Program Operation$3,907,549
UM1 · FY2016 · AI · contact PI
HIV Research for Prevention 2016: Vaccine, Microbicide and ARV-based Prevention Science (HIV R4P)$1,565,429
R13 · FY2016 · AI · contact PI
Antibody function at the portal of entry$646,142
P01 · FY2016 · AI · contact PI
Harnessing MUC16-IgG Interactions to Enhance HIV Vaccine Function$601,219
R01 · FY2016 · AI · contact PI
Virus Imaging Core$334,222
P50 · FY2016 · GM · contact PI
Core E: Viral Pathogenesis Core$227,155
P30 · FY2016 · AI · contact PI
Sustained Long Acting Prevention Against HIV Program Operation$3,609,469
UM1 · FY2015 · AI · contact PI
Identification of the Initial Targets of Transmission$958,017
R01 · FY2015 · AI · contact PI
Cervical/Vaginal Mucus and Microbicides$470,649
R33 · FY2015 · AI · contact PI
Virus Imaging Core$296,550
P50 · FY2015 · GM · contact PI
Core E: Viral Pathogenesis Core$218,305
P30 · FY2015 · AI · contact PI
Identification of the Initial Targets of Transmission$767,008
R01 · FY2014 · AI · contact PI
Cervical/Vaginal Mucus and Microbicides$476,268
R33 · FY2014 · AI · contact PI
Virus Imaging Core$288,584
P50 · FY2014 · GM · contact PI
Identification of the Initial Targets of Transmission$1,219,391
R01 · FY2013 · AI · contact PI
Cervical/Vaginal Mucus and Microbicides$466,471
R33 · FY2013 · AI · contact PI
Microscopic Analysis of the Interaction of HIV and the Human Female Genital Tract$351,093
P01 · FY2013 · AI · contact PI
Virus Imaging Core$274,330
P50 · FY2013 · GM · contact PI
Effects of Male Circumcision on Human Penile Epithelia$74,546
R03 · FY2013 · DK · contact PI
Identification of the Initial Targets of Transmission$777,559
R01 · FY2012 · AI · contact PI
Delta Vision-OMX Super-Resolution Fluorescent Microscope$600,000
S10 · FY2012 · OD · contact PI
Microscopic Analysis of the Interaction of HIV and the Human Female Genital Tract$422,419
P01 · FY2012 · AI · contact PI
Virus Imaging Core$342,643
P50 · FY2012 · GM · contact PI
Cervical/Vaginal Mucus and Microbicides$207,298
R21 · FY2012 · AI · contact PI
Effects of Male Circumcision on Human Penile Epithelia$77,250
R03 · FY2012 · DK · contact PI
Identification of the Initial Targets of Transmission$803,750
R01 · FY2011 · AI · contact PI
Microscopic Analysis of the Interaction of HIV and the Human Female Genital Tract$414,307
P01 · FY2011 · AI · contact PI
Cell Biology and HIV Entry$375,008
R01 · FY2011 · AI · contact PI
Virus Imaging Core$344,201
P50 · FY2011 · GM · contact PI
Cervical/Vaginal Mucus and Microbicides$210,450
R21 · FY2011 · AI · contact PI
Development of tissue explant models for microbicide evaluation$870,770
R33 · FY2010 · AI · contact PI
Microscopic Analysis of the Interaction of HIV and the Human Female Genital Tract$443,961
P01 · FY2010 · AI · contact PI
Cell Biology and HIV Entry$383,127
R01 · FY2010 · AI · contact PI
Intracellular Trafficking of HIV-1 Particles$370,711
R01 · FY2010 · AI · contact PI
Virus Imaging Core$340,346
P50 · FY2010 · GM · contact PI
Microscopic Analysis of the Interaction of HIV and the Human Female Genital Tract$422,963
P01 · FY2009 · AI · contact PI
Intracellular Trafficking of HIV-1 Particles$373,182
R01 · FY2009 · AI · contact PI
Development of tissue explant models for microbicide evaluation$372,356
R33 · FY2009 · AI · contact PI
Virus Imaging Core$343,534
P50 · FY2009 · GM · contact PI
Cell Biology and HIV Entry$333,295
R01 · FY2009 · AI · contact PI
Cell Biology and HIV Entry$42,623
R01 · FY2009 · AI · contact PI
Virus Imaging Core$391,696
P50 · FY2008 · GM · contact PI
Development of tissue explant models for microbicide evaluation$380,874
R33 · FY2008 · AI · contact PI
Intracellular Trafficking of HIV-1 Particles$375,468
R01 · FY2008 · AI · contact PI
Cell Biology and HIV Entry$333,295
R01 · FY2008 · AI · contact PI
Cell Biology and HIV Entry$41,214
R01 · FY2008 · AI · contact PI
Cell Biology and HIV Entry$339,750
R01 · FY2007 · AI · contact PI
Intracellular Trafficking of HIV-1 Particles$329,897
R01 · FY2007 · AI · contact PI
Virus Imaging Core$311,714
P50 · FY2007 · GM · contact PI
Development of tissue explant models for microbicide evaluation$210,035
R21 · FY2007 · AI · contact PI
Intracellular Trafficking of HIV-1 Particles$46,320
R01 · FY2007 · AI · contact PI
Intracellular Trafficking of HIV-1 Particles$225,375
R01 · FY2006 · AI · contact PI
Development of tissue explant models for microbicide evaluation$180,258
R21 · FY2006 · HD · contact PI
Intracellular Trafficking of HIV-1 Particles$336,375
R56 · FY2005 · AI
Cell Biology of HIV Entry$242,470
R01 · FY2005 · AI
Cell Biology of HIV Entry$96,390
R01 · FY2005 · AI
Cell Biology of HIV Entry$346,852
R01 · FY2004 · AI
Cell Biology of Filovirus Entry$272,773
R21 · FY2004 · AI